Vitamin B12 deficiency in the elderly and the possibility of influencing the nature of drug treatment type 2 diabetes
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The article presents data on the prevalence, causes, precipitating factors and consequences of vitamin B12 deficiency in the elderly. A possible relationship between vitamin B12 deficiency and the development of senile weakness syndrome was traced. The data from a clinical case on the positive experience of switching from metformin to metformin XR in a man with type 2 diabetes mellitus are presented.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Allen L.H. Recommended levels of folic acid and vitamin B12 fortification: Conclusions / L.H. Allen, L.B. Bailey, G.F. Chavez et al. // Nutrition Reviews. – 2004. – V. 62, No 6. – Р. 62–66.
Lindenbaum J. Prevalence of cobalamin deficiency in the Framingham elderly population / J. Lindenbaum, I.H. Rosenberg, P.W. Wilson et al. // Am. J. Clin. Nutr. – 1994. – V. 60, No 1. – Р. 2–11.
O’Leary F. Vitamin B12 in health and disease / F. O’Leary, S. Samman // Nutrients. – 2010. – V. 2, No 3. – Р. 299–316.
Rush E.C. Vitamin B12: one carbon metabolism, fetal growth and programming for chronic disease / E.C. Rush, Р. Katre, C.S. Yajnik // Eur. J. Clin. Nutr. – 2014. – V. 68, No 1. – Р. 2–7.
Сушинский В.Э. Особенности анемического синдрома в гериатрической практике / В.Э. Сушинский // Минск. – 2008. – 52 с.
Briani C. Cobalamin deficiency: clinical picture and radiological findings / С. Briani, С. Dalla Torre, V. Citton et al. // Nutrients. – 2013. – V. 5, No 11. – Р. 4521–4539.
Ocampo C.J.M. Vitamin B12 deficit and development of geriatric syndromes / C.J.M. Ocampo // Colombia Medica. – 2013. – V. 44, No 1. – Р. 42–45.
Michelon E. Vitamin and carotenoid status in older women:associations with the frailty syndrome / E. Michelon, C. Blaum, R.D. Semba et al. // J Gerontol A Biol Sci Med Sci. – 2006. – V. 61. – P. 600–607.
Matteini A.M. Transcobalamin-II variants, decreased vitamin B12 availability and increased risk of frailty / A.M. Matteini, J.D. Walston, K. Bandeen-Roche et al.// J Nutr Health Aging. – 2010. – V. 14. – P. 73–77.
Dokuzlar O. Association between serum vitamin B12 level and frailty in older adults / O. Dokuzlar, P. Soysal, A.T. Isik // North Clin Istanb. – 2017. – V. 4 (1). – P. 22–28.
Гавалко Ю.В. Дефіцит вітаміну В12 у людей літнього та старечого віку / Ю.В. Гавалко // Пробл. старения и долголетия. – 2015. – Т. 24, No 1. – С. 78–87.
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes/ Inzucchi S.E., Bergenstal R.M., Buse J.B., Diamant M., Ferrannini E., Nauck M., Peters A.L., Tsapas A., Wender R., Matthews D.R . // Diabetes Care. – 2015. – V. 38 (1). – P. 140–149.
Wu H. Metformin alters the gut microbiome of individuals with reatmentnaive type 2 diabetes, contributing to the therapeutic effects of the drug / Н. Wu, Е. Esteve, V. Tremaroli, М.Т. Khan, R. Caesar et al. // Nat. Med. – 2017. – V. 23. – Р. 850–858.
Kos E. Effect of metformin therapy on vitamin D and vitamin B12 levels in patients with type 2 diabetes mellitus / Е. Kos, М. Liszek, М. Emanuele, R. Durazo-Arvizu, Р. Camacho // Endocr Pract. – 2012. – V. 18. – Р. 179–184.
De-Jager J. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial / J. De-Jager, А. Kooy, Р. Lehert // BMJ. – 2010. – V. 340. – Р. 21–81.
Chapman L. E. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis / L.E. Chapman, A.L. Darling, J.E. Brown // Diabetes Metab. – 2016. – V. 42 (5). – Р. 316–327.
Association of metformin use with vitamin B12 deficiency in the institution-alized elderly / Wong Chit Wai, Leung Chi Shing, Leung Chung Ping, Cheng Jen Ngai // Archives of Gerontology and Geriatrics. – 2018. – V. 79. – Р. 57–62.
Metformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Qianying Zhang, Sheyu Li, Ling Li, Qianrui Li, Kaiyun Ren, Xin Sun, Jianwei Li // Nutrients. – 2016. – V. 8 (12). – 798 р.
Moore E. M. Increased risk of cognitive impairment in patients with diabetes is associated with metformin / E.M. Moore, A.G. Mander, D. Ames, M.A. Kotowicz et al. // Diabetes Care. – 2013. – V. 36. – Р. 2981–2987.
Liu Q. Vitamin B12 status in metformin treated patients: Systematic review / Q. Liu, S. Li, H. Quan, J. Li // PLoS ONE. – 2014. – V. 9.
Glucophage (metformin hydrochloride) and Glucophage XR (extended-release) US prescribing information // Bristol-Myers Squibb, Bristol, NJ, USA. – 2009. Available from http: // packagein-serts.bms.com/pipi_glucophage_xr.pdf.
Derosa G. Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes / G. Derosa, A. D’Angelo, D. Romano, P. Maffioli // Drug Des Devel Ther. – 2017. – V. 11. – Р. 1481–1488.
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials / Ralph A. DeFronzo, John B. Buse, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron, Mark Fineman // Diabetologia. – 2016. – V. 59. – Р. 1645–1654.
Ting R.Z.W., Szeto C.C., Chan M.H.M., Ma K.K., Chow K.M. Risk factors of vitamin B12 deficiency in patients receiving metformin / R.Z.W. Ting, С.С. Szetо, M.H.M. Chan et al. // Arch Intern Med. – 2006. – V. 166. – Р. 1975–1979.
